|
Market Closed -
Nasdaq
01:00:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.340 USD | +24.16% |
|
+9.15% | -94.16% |
| 10-23 | Immutep Limited Announces Health-Related Quality of Life Data from Eftisarc-Neo Phase Ii Trial | CI |
| 10-14 | Immutep outlines clinical development priorities and plans for 2027 | FI |
Company Valuation: Immutep Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 247.7 | 374 | 420.2 | 350.5 | 78.11 | 30.95 | - | - |
| Change | - | 50.99% | 12.36% | -16.6% | -77.72% | -60.38% | - | - |
| Enterprise Value (EV) 1 | 169.2 | 251.4 | 259.4 | 284.2 | 14.43 | -23.65 | -2.885 | -28.72 |
| Change | - | 48.63% | 3.18% | 9.55% | -94.92% | -263.85% | 87.8% | -895.38% |
| P/E | -7.65x | -7.05x | -8.29x | -5.69x | -0.98x | -1.24x | -1.91x | -2.86x |
| PBR | 2.62x | 2.74x | 2.26x | 2.43x | 1.27x | 1.68x | 3.5x | 0.42x |
| PEG | - | -0.4x | 0.4x | -0.3x | -0x | 0x | 0.1x | 0.1x |
| Capitalization / Revenue | 36.7x | 71.9x | 53.6x | 33.9x | 3.23x | 7.74x | 10.3x | 15.5x |
| EV / Revenue | 25x | 48.3x | 33.1x | 27.5x | 0.6x | -5.91x | -0.96x | -14.4x |
| EV / EBITDA | -5.63x | -6.65x | -6.42x | -4.82x | -0.19x | 0.85x | 0.13x | 1.69x |
| EV / EBIT | -5.27x | -6.31x | -6.08x | -4.63x | -0.18x | 0.68x | 0.09x | 1.02x |
| EV / FCF | -5.59x | -7.09x | 7.46x | -4.58x | -0.26x | 0.95x | 0.13x | 2.13x |
| FCF Yield | -17.9% | -14.1% | 13.4% | -21.8% | -385% | 106% | 745% | 47% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.0379 | -0.0447 | -0.0356 | -0.0422 | -0.0539 | -0.017 | -0.011 | -0.00733 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 6.758 | 5.2 | 7.839 | 10.33 | 24.17 | 4 | 3 | 2 |
| EBITDA 1 | -30.05 | -37.81 | -40.42 | -59.01 | -76.76 | -27.67 | -22.03 | -17.03 |
| EBIT 1 | -32.12 | -39.88 | -42.69 | -61.4 | -79.24 | -34.86 | -32.96 | -28.18 |
| Net income 1 | -32.21 | -39.9 | -42.72 | -61.43 | -79.3 | -30.92 | -28 | -24.93 |
| Net Debt 1 | -78.54 | -122.6 | -160.8 | -66.3 | -63.67 | -54.6 | -33.83 | -59.67 |
| Reference price 2 | 0.2900 | 0.3150 | 0.2950 | 0.2400 | 0.0530 | 0.0210 | 0.0210 | 0.0210 |
| Nbr of stocks (in thousands) | 854,123 | 1,187,306 | 1,424,548 | 1,460,390 | 1,473,721 | 1,473,721 | - | - |
| Announcement Date | 31/08/22 | 29/08/23 | 29/08/24 | 28/08/25 | 30/08/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.43x | 6.6x | 12.65x | 1.71% | 66.7B | |
| 30.07x | 8.27x | 26.77x | 0.06% | 56.88B | |
| 38.45x | 6.85x | 20.42x | 0.85% | 56.53B | |
| 49.29x | 6.27x | 34.36x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.45x | 63.4x | -21.48x | -.--% | 41.59B | |
| 35.89x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 37.6x | 8.06x | 26.12x | -.--% | 33.29B | |
| -69.1x | 13.21x | -71.01x | -.--% | 25.1B | |
| Average | 16.96x | 13.87x | 7.26x | 0.33% | 45.19B | |
| Weighted average by Cap. | 21.59x | 13.00x | 11.74x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
- Valuation Immutep Limited
Select your edition
All financial news and data tailored to specific country editions
